Djibouti vs Senegal: HIV-positive TB patients on ART (antiretroviral therapy)
Djibouti
71.0%
in 2024
Senegal
74.0%
in 2024
Djibouti rank
124th
Senegal rank
121st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Djibouti
- Senegal
How they compare
Senegal currently reports 74.0% against 71.0% in Djibouti, a difference of 3.0%.
The two have swapped places 4 times across 16 shared years of data; in 2008 it was Senegal ahead.
Djibouti ranks 124th and Senegal ranks 121st of 144 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.0% | 30.5% | 4.5% | Senegal |
| 2010s | 55.6% | 76.9% | 21.3% | Senegal |
| 2020s | 56.2% | 88.5% | 32.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Djibouti or Senegal?
- Senegal, at 74.0% against 71.0% in Djibouti as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Djibouti and Senegal?
- 3.0%, with Senegal ahead.
- How many years of comparable data are there for Djibouti and Senegal?
- 16 years are reported by both, from 2008 to 2024.
- How do Djibouti and Senegal rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Djibouti ranks 124th and Senegal ranks 121st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.